Register entry
- Registered sites
- 1
- Active NDC listings
- 12
- Live patents
- 0
- Countries
- 1
- Base
- Canada
Authorisation
Registered operations
Analytical testing1Labelling1Finished drug manufacture1Packaging1
Sites
Registered establishments
1| Establishment | Address | Registered for | FEI / DUNS |
|---|---|---|---|
| Kenvue Canada Inc. | 890 Woodlawn Rd W, Guelph, Ontario N1K 1A5, Canada (CAN) | Analytical testing, Labelling, Finished drug manufacture, Packaging | 1000328785243868374 |
Catalogue
Drug listings by form and route
1212 active NDC listings: 12 drug for further processing. By marketing category: DRUG FOR FURTHER PROCESSING 12.
| Dosage form | NDCs |
|---|---|
| tablet, chewable | 5 |
| tablet, film coated | 5 |
| tablet, coated | 2 |
| Route | NDCs |
|---|
| Labeller name on the listing | NDCs |
|---|---|
| kenvue canada inc. | 12 |
Catalogue
Marketed products
12| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| - | Acetaminophen and Dextromethorphan Hydrobromide | tablet, film coated | 65498-446DRUG FOR FURTHER PROCESSING |
| - | Acetaminophen, Dextromethorphan Hydrobromide, and Chlorpheniramine Maleate | tablet, film coated | 65498-551DRUG FOR FURTHER PROCESSING |
| - | Acetaminophen, Pseudoephedrine Hydrochloride, Dextromethorphan Hydrobromide, and Chlorpheniramine Maleate | tablet, film coated | 65498-286DRUG FOR FURTHER PROCESSING |
| - | Acetaminophen, Pseudoephedrine Hydrochloride, and Dextromethorphan Hydrobromide | tablet, film coated | 65498-344DRUG FOR FURTHER PROCESSING |
| - | Cetirizine Hydrochloride | tablet, chewable | 65498-753DRUG FOR FURTHER PROCESSING |
| - | Cetirizine Hydrochloride | tablet, chewable | 65498-790DRUG FOR FURTHER PROCESSING |
| - | Cetirizine Hydrochloride | tablet, chewable | 65498-791DRUG FOR FURTHER PROCESSING |
| - | Cetirizine Hydrochloride | tablet, chewable | 65498-792DRUG FOR FURTHER PROCESSING |
| - | Diphenhydramine Hydrochloride | tablet, chewable | 65498-232DRUG FOR FURTHER PROCESSING |
| - | Paracetamol | tablet, coated | 65498-108DRUG FOR FURTHER PROCESSING |
| - | Paracetamol | tablet, coated | 65498-475DRUG FOR FURTHER PROCESSING |
| - | Pseudoephedrine Hydrochloride | tablet, film coated | 65498-363DRUG FOR FURTHER PROCESSING |
Compare
Comparable companies in Canada
- Rejoice Industries Canada Inc1 site · 139 NDC
- AX Pharmaceutical Corp1 site · 123 NDC
- Bausch Health US, LLC1 site · 93 NDC
- Delmar Chemicals Inc1 site · 19 NDC
- E-Z-EM Canada Inc1 site · 18 NDC
- Bispit Canada Ltd1 site · 12 NDC
- Novocol Pharmaceutical of Canada, Inc.1 site · 12 NDC
- Diversey Canada, Inc1 site · 9 NDC
- Natures Formulae Health Products Ltd.1 site · 9 NDC
- Laboratoires Delon1 site · 6 NDC
Enquiry
Common questions
- Is Kenvue Canada Inc. FDA approved?
- Kenvue Canada Inc. holds 1 FDA-registered establishment in Canada. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
- Where are Kenvue Canada Inc.'s drugs manufactured?
- The FDA register lists Guelph. Registered operations: analytical testing, labelling, finished drug manufacture, packaging.
- What drugs does Kenvue Canada Inc. make?
- 12 products are listed under Kenvue Canada Inc. in the openFDA NDC Directory, most often as tablet, chewable; tablet, film coated; tablet, coated. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.